Clarus Therapeutics Files for Chapter 11
Clarus Therapeutics, together with its wholly-owned subsidiary Clarus Therapeutics, has filed voluntary petitions under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware.